News
Pinned
Synergus RWE medtech market access continues as athagoras Medtech
Strategy, evidence, value communication, reimbursement execution and real-world evidence across Europe, the UK and Ireland.
2 abstracts presented from diabetes RWE research
Research on FreeStyle Libre using the Swedish diabetes registry linked with other data sources.
Synergus RWE medtech market access continues at athagoras Medtech
Joining forces to become a leader in European market access for medical devices and digital health.
30 successful NUB applications 2022
Achieved by our partner Dr Martin Braun.